Soft Tissue Repair Market accounted 18537.0 USD million in 2020 and is expected to reach 31965.3 USD million by 2030 growing with a CAGR of 5.6% during the forecast period.Damage of muscle, ligaments, tendons which cause pain and inflammation these injuries are known as soft tissue injuries. Soft tissue repair is the process of replacement of the damaged soft tissue with a new one. For instance, the process is performed using surgical operation due to which chances of success are very less. Hence it is necessary to find the method in which minimally invasive and uses rapid healing products. Research and development in the market are also providing advanced devices. This technique is mostly used for sports-related injuries. These sports injuries are not just faced by the players but also faced by kids while playing sports. According to the United States Centre for Disease Control, high school athletes suffer from 2 million injuries every year and 3.5 million kids below age 14 receives medical treatment for a sports injury. Therefore growing injuries in sports, accidents will fuel the growth of the market.
Market Segmentation:
On the basis type, the soft tissue repair market is segmented into tissue mesh, a laparoscopic instrument, and a fixation device. On the basis of application, the market is segmented into breast reconstruction, dental repair, dural repair, head and neck products, hernia repair, orthopedic repair, pelvic and vaginal purpose, and skin repair. By region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, and RoW.Market Dynamics and Factors:
Major driving factors of this market include the rise in an obese population. Increasing unhealthy lifestyles in the urbanized region lead to obesity. In addition to this, participation in outdoor sport is increasing coupled with an increase in health awareness results in more participation towards outdoor sports. The soft tissue repair method is very useful to heal the injuries caused during the sport. The growing healthcare sector in emerging countries and growing awareness about the benefits of tissue replacement will further boost the soft tissue repair market in upcoming years. However, the process involves surgical operation which reduces the chances of success chances. Hence, research and development is working on it in order to gain technological advancement, which is expected to create more opportunities in future.Geographic Analysis:
North America has already dominated the soft tissue repair market in 2017 and expected to continue its supremacy during the forecast period, owing to well-established healthcare sector. Growing awareness in citizens regarding the benefits of tissue repairing. Coupled with, Growing popularity of the sport in all age groups all these factors will support the growth of the soft tissue repair market in North America. Asia Pacific is also expected to witness rapid growth with the rising healthcare sector, growing unhealthy lifestyle in urban areas leads to obesity. Growing population and growing participation in sport all these factors will cater to the growth of the soft tissue repair market India. Europe already has well established healthcare sector and the market in Europe is growing with significant rate and expected to continue its growth in upcoming years.Competitive Scenario:
Key players in the soft tissue repair market are Allergan Plc. (LifeCell Corporation), Athersys Inc., CryoLife Inc., Medtronic Plc., Organogenesis Inc., Integra Lifesciences Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith Nephew plc., and Becton.
Soft Tissue Repair Market Report Scope
| Report Attribute | Details |
| Analysis Period | 2020–2030 |
| Base Year | 2021 |
| Forecast Period | 2022–2030 |
| Market Size Estimation | Million (USD) |
| Growth Rate (CAGR%) | 5.6 % |
|
| By Type (Tissue Mesh, Laparoscopic Instrument, and Fixation Device), By Application (Breast Reconstruction, Dental Repair, Dural Repair, Head & Neck Products, Hernia Repair, Orthopaedic Repair, Pelvic and Viginal Prolapse, and Skin Repair) |
| Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
| Key Companies Profiled | Allergan Plc. (LifeCell Corporation), Athersys Inc., CryoLife Inc., Medtronic Plc., Organogenesis Inc., Integra Lifesciences Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith Nephew plc., and Becton. |
